|
N-(furan-2-ylmethylcarbamoyl)-2-(4-oxobenzo[g]quinazolin-3-yl)acetamide |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
[2-[[(1R,2R)-2-methylcyclohexyl]carbamoylamino]-2-oxoethyl] 4-oxo-3-phenylphthalazine-1-carboxylate |
Depiction based on curated SMILES
N
N
O
O
N
H
H
H
H
3
C
O
N
H
O
O
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
Lapatinib |
Depiction based on curated SMILES
O
N
NH
F
Cl
S
O
O
N
H
CH
3
O
N
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Manzer HS, et al. 2022. PLoS Pathog |
|
1-(tert-butyl)-7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-napthyridine-3-carboxylic acid |
Depiction based on curated SMILES
N
Cl
F
O
CH
3
HO
O
N
H
3
C
H
3
C
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Na SH, et al. 2021. J Microbiol |
|
[6,7-bis(chloranyl)-3-phosphono-quinoxalin-2-yl]phosphonic acid |
Depiction based on curated SMILES
OH
OH
O
P
OH
OH
O
P
N
N
Cl
Cl
|
Bacillus Clostridium |
Collagenase Collagenase |
Preclinical (in vitro) Preclinical (in vitro) |
Alhayek A, et al. 2022. J Med Chem
|
|
[6-(4-chlorophenyl)-3-phosphonoquinoxalin-2-yl]phosphonic acid |
Depiction based on curated SMILES
N
Cl
OH
OH
O
P
OH
OH
O
P
N
|
Bacillus Clostridium |
Collagenase Collagenase |
Preclinical (in vitro) Preclinical (in vitro) |
Alhayek A, et al. 2022. J Med Chem
|
|
2-(2-Pyridin-3-yl-vinyl)-3-m-tolyl-3H-quinazolin-4-one |
Depiction based on curated SMILES
N
O
H
3
C
N
N
|
Klebsiella |
Aerobactin |
Preclinical (in vitro) |
Bailey DC, et al. 2018. SLAS Discov |
|
N-(2,5-dimethylphenyl)-2-(4-oxo-3(4H)-quinazolinyl)acetamide |
Depiction based on curated SMILES
O
N
N
CH
3
O
N
H
CH
3
|
Mycobacterium |
Immune modulation |
Preclinical (in vitro) |
Karanja CW, et al. 2021. ACS Infect Dis |
|
N-(2-methyl-5-nitrophenyl)-2-(4-oxoquinazolin-3(4H)-yl)acetamide |
Depiction based on curated SMILES
O
O
N
N
H
3
C
N
H
_
O
O
+
N
|
Mycobacterium |
Immune modulation |
Preclinical (in vitro) |
Karanja CW, et al. 2021. ACS Infect Dis |
|
N-(5-chloro-2-methylphenyl)-2-(4-oxo-3(4H)-quinazolinyl)acetamide |
Depiction based on curated SMILES
O
N
N
CH
3
O
N
H
Cl
|
Mycobacterium |
Immune modulation |
Preclinical (in vitro) |
Karanja CW, et al. 2021. ACS Infect Dis |
|
| | |